Development of invasive and growth factor-independent cell variants from primary human melanomas.

Growth autonomy and high levels of invasiveness are characteristics of human melanoma cells that are metastatic in vivo. By consecutive passage through a reconstructed basement membrane, we have selected from 5 of 6 primary melanoma cell lines variants which show an up to 10-fold increase in invasiveness. The invasive variants grew more rapidly than the parental, noninvasive cells in serum- and growth factor-free medium and one of the 3 variant cell lines with the highest invasive capacity in vitro metastasized to the lungs when injected s.c. into nude mice. In a second approach, variants of 6 primary melanoma cell lines were clonally selected in medium without exogenous growth factors (protein-free medium). These selected cells showed higher invasive properties in vitro and in vivo than the parental cells. Clones of invasive and growth factor-independent cell variants were heterogenous and changed over time in the absence of selected pressure to a phenotype similar to that of parental nonselected cells. These results indicate that primary melanoma cells contain subpopulations of cells that have the phenotype of an advanced (metastatic) stage of tumor progression, but this phenotype is not stable without selective pressure.

[1]  M. Herlyn,et al.  Regulatory pathways in tumor growth and invasion. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[2]  M. Herlyn,et al.  Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor‐derived EGF/TGF‐α , 1990, Journal of cellular biochemistry.

[3]  D. Iliopoulos,et al.  In vitro properties of human melanoma cells metastatic in nude mice. , 1990, Cancer research.

[4]  M. Herlyn,et al.  Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. , 1989, The EMBO journal.

[5]  D. Elder,et al.  Tumor progression in the human melanocytic system. , 1989, Anticancer research.

[6]  R. Kerbel,et al.  Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. , 1989, Journal of the National Cancer Institute.

[7]  D. Guerry,et al.  Production of interleukin 1 activity by cultured human melanoma cells. , 1989, Cancer research.

[8]  R. Kerbel,et al.  Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. , 1988, Cancer research.

[9]  B. Kwon,et al.  bFGF as an autocrine growth factor for human melanomas. , 1988, Oncogene research.

[10]  R. Derynck,et al.  Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. , 1988, The EMBO journal.

[11]  A. Lagarde,et al.  Coincidental acquisition of growth autonomy and metastatic potential during the malignant transformation of factor-dependent CCL39 lung fibroblasts. , 1988, Journal of the National Cancer Institute.

[12]  I. Fidler,et al.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. , 1988, Cancer research.

[13]  M. Herlyn,et al.  Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors , 1987, International journal of cancer.

[14]  S. Ethier,et al.  Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat mammary carcinoma cells. , 1987, Cancer research.

[15]  M. Herlyn,et al.  Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. , 1987, Cancer research.

[16]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[17]  W. Clark,et al.  Biology of tumor progression in human melanocytes. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[18]  D. Rifkin,et al.  Both normal and tumor cells produce basic fibroblast growth factor , 1986, Journal of cellular physiology.

[19]  C. Heldin,et al.  Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Clark,et al.  The biologic forms of malignant melanoma. , 1986, Human pathology.

[21]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[22]  P. Nowell,et al.  Characteristics of cultured human melanocytes isolated from different stages of tumor progression. , 1985, Cancer research.

[23]  P. Nowell,et al.  Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. , 1985, Journal of the National Cancer Institute.

[24]  M. N. Epstein,et al.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.

[25]  V. Ling,et al.  Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. , 1984, Science.

[26]  P. Nowell,et al.  Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.

[27]  S. Boyce,et al.  Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. , 1983, The Journal of investigative dermatology.

[28]  A. Richmond,et al.  Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. , 1983, Cancer research.

[29]  G. Todaro,et al.  Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization. , 1982, The Journal of biological chemistry.

[30]  W. Clark,et al.  Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. , 1980, Cancer research.

[31]  C. Keysser Neoplastic Development, Vol. 2 , 1976 .

[32]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[33]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[34]  H. Kung,et al.  Expression and release of interleukin-1 by different human melanoma cell lines. , 1989, Journal of the National Cancer Institute.

[35]  J. D. De Larco,et al.  Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. , 1985, Ciba Foundation symposium.

[36]  M. Herlyn,et al.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. , 1984, The Journal of clinical investigation.